Tag: Ascendis Pharma A/S

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ascendis Pharma A/S

Ascendis Pharma A/S (ASND) Receives $77.25 Average PT from Brokerages

Added to Collection on: 2018-10-02 19:15:00

Tags for this article:

Finance
OrbiMed
Economy
Securities research
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Has $37.73 Million Position in Ascendis Pharma A/S (ASND)

Added to Collection on: 2018-10-07 14:22:30

Tags for this article:

OrbiMed
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Wedbush Reiterates $191.00 Price Target for Ascendis Pharma A/S (NASDAQ:ASND)

Added to Collection on: 2019-09-20 08:00:00

Tags for this article:

Economy of New York City
NASDAQ
Finance
Service companies
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual JP Morgan Healthcare Conference

Added to Collection on: 2021-01-11 00:00:00

Tags for this article:

Health sciences
Health
Clinical research
Design of experiments
Drug discovery
Pharmaceutical industry
Growth hormone therapy
Clinical trial
Ascendis Pharma Group
Copenhagen
Ascendis Pharma A/S
Denmark

Click the tags to see associated articles and topics

View Article Details
Traders Purchase High Volume of Ascendis Pharma A/S Call Options (NASDAQ:ASND)

Added to Collection on: 2021-04-21 07:41:00

Tags for this article:

Life Sciences
Zealand Pharma
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma A/S Stock Shows Every Sign Of Being Modestly Undervalued

Added to Collection on: 2021-04-25 07:07:30

Tags for this article:

Finance
Money
Economy
Financial ratios
Financial capital
Mathematical finance
Return on capital
Investment
Valuation
Weighted average cost of capital
Cost of capital
Return on investment
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical ...

Added to Collection on: 2021-05-06 20:17:37

Tags for this article:

Communication
Forward-looking statement
Ascendis Pharma Group
Ascendis Pharma A/S

Click the tags to see associated articles and topics

View Article Details
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for ... - PR Newswire

Added to Collection on: 2024-01-07 19:19:34

Tags for this article:

Rare diseases
Peptide hormones
Growth hormones
Orphan drugs
Dwarfism
Palopegteriparatide
Growth hormone therapy
Growth hormone
Hypoparathyroidism
Achondroplasia
Parathyroid hormone
Parathyroid gland
Ascendis Pharma A/S
Ascendis Pharma
hGH

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma A/S (NASDAQ:ASND) Given New $140.00 Price Target at Morgan Stanley

Added to Collection on: 2024-05-18 16:53:59

Tags for this article:

Equity securities
Corporate finance
Financial capital
Private equity
Stock
Stock market
Kite Pharma
Zealand Pharma
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Latham & Watkins Advises Ascendis Pharma in US $150 Million Royalty Financing

Added to Collection on: 2024-09-04 22:18:55

Tags for this article:

Expense
Intellectual property law
Patent law
Royalty payment
Royalty fund
Royalty Pharma plc
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Book a Demo